Literature DB >> 20339991

Mediastinal metastasis from a fibrolamellar hepatocellular carcinoma: Report of a case.

Yoshinobu Ichiki1, Kenji Sugio, Tetsuro Baba, Makiko Mizukami, Takeshi Oga, Mitsuhiro Takenoyama, Takeshi Hanagiri, Koji Okamoto, Koji Yamaguchi, Satoshi Katagiri, Masakazu Yamamoto, Kosei Yasumoto.   

Abstract

Fibrolamellar hepatocellular carcinoma (FL-HCC) is an uncommon clinicopathological variant of hepatocellular carcinoma (HCC). The etiology of FL-HCC is unknown, but FL-HCC is not associated with hepatic viruses or alcohol. Hepatocellular carcinoma usually occurs in cases of chronic hepatitis or cirrhosis, whereas FL-HCC predominantly occurs in a normal liver and in younger adults. Fibrolamellar HCC shows relatively slow growth, and late recurrence is common. Repeated resections for recurrences should be considered not only because there is a lack of other effective treatment options but also because FL-HCC shows a relatively better prognosis after a resection in comparison to common HCC. This report presents a case of a rare mediastinal metastasis from FL-HCC in a patient who had undergone a previous resection for retroperitoneal metastasis after the initial hepatic operation. This is the second report of the same case. This patient also had a mediastinal neurogenic tumor, and these mediastinal tumors were concurrently resected.

Entities:  

Mesh:

Year:  2010        PMID: 20339991     DOI: 10.1007/s00595-009-4035-4

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  14 in total

1.  Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation.

Authors:  A D Pinna; S Iwatsuki; R G Lee; S Todo; J R Madariaga; J W Marsh; A Casavilla; I Dvorchik; J J Fung; T E Starzl
Journal:  Hepatology       Date:  1997-10       Impact factor: 17.425

2.  Fibrolamellar carcinoma of the liver. Review of three cases and the presentation of a characteristic set of tumor markers defining this tumor.

Authors:  D H Teitelbaum; S Tuttle; L C Carey; K P Clausen
Journal:  Ann Surg       Date:  1985-07       Impact factor: 12.969

3.  Fibrolamellar hepatocarcinoma: radiology, management, and pathology.

Authors:  L K Wong; D P Link; C F Frey; R H Ruebner; H Tesluk; N R Pimstone
Journal:  AJR Am J Roentgenol       Date:  1982-07       Impact factor: 3.959

4.  Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases.

Authors:  T Ichikawa; M P Federle; L Grazioli; J Madariaga; M Nalesnik; W Marsh
Journal:  Radiology       Date:  1999-11       Impact factor: 11.105

5.  Outcome of liver resection and transplantation for fibrolamellar hepatocellular carcinoma.

Authors:  G El-Gazzaz; W Wong; M K El-Hadary; B K Gunson; D F Mirza; A D Mayer; J A Buckels; P McMaster
Journal:  Transpl Int       Date:  2000       Impact factor: 3.782

Review 6.  Fibrolamellar hepatoma.

Authors:  M T Ruffin
Journal:  Am J Gastroenterol       Date:  1990-05       Impact factor: 10.864

7.  Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma.

Authors:  Kiminori Uka; Hiroshi Aikata; Shintaro Takaki; Hiroo Shirakawa; Soo-Cheol Jeong; Keitaro Yamashina; Akira Hiramatsu; Hideaki Kodama; Shoichi Takahashi; Kazuaki Chayama
Journal:  World J Gastroenterol       Date:  2007-01-21       Impact factor: 5.742

8.  Extrahepatic spread from hepatocellular carcinoma: who are candidates for aggressive anti-cancer treatment?

Authors:  Hiroshi Ishii; Junji Furuse; Taira Kinoshita; Masaru Konishi; Toshio Nakagohri; Shinichiro Takahashi; Naoto Gotohda; Kouhei Nakachi; Masahiro Yoshino
Journal:  Jpn J Clin Oncol       Date:  2004-12       Impact factor: 3.019

9.  Aggressive surgical management of fibrolamellar hepatocellular carcinoma.

Authors:  A W Hemming; B Langer; P Sheiner; P D Greig; B R Taylor
Journal:  J Gastrointest Surg       Date:  1997 Jul-Aug       Impact factor: 3.452

10.  Outcome of patients with fibrolamellar hepatocellular carcinoma.

Authors:  Francesco Stipa; Sam S Yoon; Kui Hin Liau; Yuman Fong; William R Jarnagin; Michael D'Angelica; G Abou-Alfa; Leslie H Blumgart; Ronald P DeMatteo
Journal:  Cancer       Date:  2006-03-15       Impact factor: 6.860

View more
  3 in total

Review 1.  Typical fibrolamellar hepatocellular carcinoma in a Japanese boy: report of a case.

Authors:  Masanori Matsuda; Hidetake Amemiya; Hiromichi Kawaida; Hirotaka Okamoto; Naohiro Hosomura; Masami Asakawa; Katsuhiro Sano; Utaroh Motosugi; Tomoaki Ichikawa; Tadao Nakazawa; Hideki Fujii
Journal:  Surg Today       Date:  2013-07-05       Impact factor: 2.549

2.  CT and MRI of primary and metastatic fibrolamellar carcinoma: a case series of 37 patients.

Authors:  R K G Do; A McErlean; C S Ang; R P DeMatteo; G K Abou-Alfa
Journal:  Br J Radiol       Date:  2014-06-04       Impact factor: 3.039

3.  Duodenal Recurrence of Fibrolamellar Carcinoma 12 Years After Partial Hepatectomy and Adjuvant Chemotherapy.

Authors:  Héctor Adrián Díaz Hernández; Ismael Antonio Gómez Ruiz; Aldo Torre
Journal:  ACG Case Rep J       Date:  2016-11-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.